AMGN שווי כולל של נכסי החברה Amgen Corp

Amgen Inc. (AMGN) is recognized as a global biotechnology leader, developing highly complex medications for the treatment of severe pathologies. The company minimizes patent expiration risks through expansion into cardiology and oncology, leveraging the loyalty of physicians and patients. This chart's price trend for total asset value, which reached 91741.87, underscores the stability of a business shielded from geopolitical shocks by the humanitarian status of its products.

Amgen Inc. (AMGN) is expanding its scientific and technological foundation through the acquisition of biotech startups and licensing agreements. This expansion is reverse-digitized via the ROA ratio, combining the value of equity and external liabilities. Growth in this metric reflects the scaling of the resource base, although it creates risks of declining operational efficiency. By analyzing total assets, an investor assesses the real dynamics of business expansion between official reports.